submission to two countries [Regulatives / Guidelines]

posted by sarada06884 – India, 2013-07-06 13:10 (4742 d 02:33 ago) – Posting: # 10951
Views: 3,014

Dear All,

Can a Bioequivalence study planned as a three way cross over study i.e. one test and two refrence formulations be submitted to two different countries. One of the reference formulations will be from UK and the study will be for submission to MHRA and the the other reference formulation shall be from USA and will be for submission to USFDA. The protocol shall be designed based on guidelines of both the countries. So now can this study be submitted to both UK MHRA and USFDA since this study is conducted based on the guidences of both the countries and reference IPs have been procured from both the countries?

Thanks and regards
P.S.Srinivas

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
330 visitors (0 registered, 330 guests [including 16 identified bots]).
Forum time: 15:44 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5